Lopezia racemosa
Lopezia racemosa · Accepted scientific name
Scientific literature: Very Sparse (9 studies) · ★☆☆☆☆
Lopezia racemosa is a botanical species that has garnered significant scientific interest due to its diverse range of biological activities. Research focusing on the plant's leaves has demonstrated potent antibacterial, antifungal, and antimicrobial properties. Furthermore, studies indicate that various components of this plant exhibit cytotoxic and antiparasitic potential. These therapeutic effects have been investigated through different preparations, including leaf extracts, specific fractions like FD (28-29), and the LRTC3.1 callus line. Advanced biotechnological approaches, such as the use of transformed plant cell cultures, continue to uncover the medicinal value of this unique species.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Onagraceae
- Distribution
- Not available
- Plant Parts
- Leaf
Classification
Common Names
Lopezia racemosa is a fascinating botanical species known by a wide variety of regional and descriptive names. In English-speaking circles, it is most frequently referred to as the Mosquito Flower due to its unique appearance. Depending on the linguistic context, you might also encounter it called Alfilerillo or Mexikanische Lopezie. Other specific designations include the Swedish term enmansblomma and the Portuguese variation lopézia strapcovitá. These diverse names highlight the global interest and cultural presence of this distinctive plant.
Sources: Catalogue of Life (COL)
Taxonomy
Lopezia racemosa is a fascinating botanical specimen belonging to the kingdom Plantae. Within this vast biological realm, the plant is classified under the class Equisetopsida. It is further organized into the order Myrtales, showcasing its specific evolutionary lineage. As a member of the family Onagraceae, it shares common traits with several other unique flowering species. Ultimately, this plant is identified by its distinct genus, Lopezia.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Myrtales |
| Family | Onagraceae |
| Genus | Lopezia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Lopezia racemosa exhibits a wide geographical distribution that spans across two major continents. In Europe, the species can be found throughout Middle Europe and Germany, as well as within the northern regions of Sweden. Its presence extends significantly into North America, where it is well-established across various parts of Mexico. Specifically, the plant inhabits diverse Mexican landscapes, including the Central, Gulf, and Northeast regions. This broad range highlights the adaptability of the species to different environmental conditions.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Lopezia racemosa is characterized by its distinctive growth form as an herb.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Lopezia racemosa is a Mexican medicinal plant recognized for its diverse range of potent biological activities. Scientific investigations have confirmed that this species possesses significant antibacterial and antifungal properties, making it a valuable subject for pharmacological study. Furthermore, the plant exhibits strong antimicrobial capabilities through its bioactive secondary metabolites. Research also highlights its cytotoxic effects, particularly against various human cancer cell lines, which underscores its therapeutic potential. Finally, the presence of antioxidant activity further demonstrates the multifaceted medicinal importance of this remarkable plant.
Compounds
Conditions
Lopezia racemosa demonstrates significant therapeutic potential through its diverse biological activities. The plant extracts are effective in treating inflammation, as evidenced by their ability to inhibit interleukin-6 secretion and reduce paw edema. Research also confirms that Lopezia racemosa treats cytotoxic targets, showing potent effects against various human cancer cell lines. Furthermore, the species provides medicinal benefits by acting as an antibacterial agent against multiple bacterial species. Finally, the plant is recognized for its ability to treat fungal infections through its antifungal properties.
Preparations
Lopezia racemosa is prepared as extracts and crude extracts to investigate its various antimicrobial, antiparasitic, and anti-inflammatory activities. Researchers also utilize transformed plant cell cultures of the species as a biotechnological approach to produce pharmacologically relevant substances. Within these studies, the LRTC3.1 callus line is specifically generated from hairy roots to aid in the identification of bioactive compounds. Furthermore, the plant is processed into specific fractions, including FD (28-29), which have demonstrated potent cytotoxic effects against cancer cell lines. These diverse preparation methods highlight the plant's potential as a valuable source for therapeutic development.
Parts used
Lopezia racemosa is a medicinal plant widely recognized by indigenous communities for its significant therapeutic properties. Recent biotechnological research has utilized the leaf of this species to generate hairy roots through infection with Agrobacterium rhizogenes. These leaf-derived explants were used to establish the LRTC3.1 callus line for the production of bioactive compounds. Through phytochemical analysis, researchers successfully isolated unique pentacyclic triterpene esters from these transformed cultures. Ultimately, the extracts derived from this process demonstrated potent anti-inflammatory and cytotoxic activities against various human cancer cell lines.